Knowledge-based approaches to drug discovery for rare diseases
- 27 October 2021
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 27 (2) , 490-502
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (GM122196-02A1)
- National Institute of Neurological Disorders and Stroke (3R43NS107079-01S1)
- National Center for Advancing Translational Sciences (OT2TR003441)
- Research Opportunities Initiative, University of North Carolina
- National Institutes of Health (1U01CA207160)
This publication has 105 references indexed in Scilit:
- A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat AgentsPLOS ONE, 2013
- Ivacaftor: A Novel Gene-Based Therapeutic Approach for Cystic FibrosisThe Journal of Pediatric Pharmacology and Therapeutics, 2013
- Principles of early drug discoveryBritish Journal of Pharmacology, 2011
- Mining connections between chemicals, proteins, and diseases extracted from Medline annotationsJournal of Biomedical Informatics, 2010
- What is biomedical informatics?Journal of Biomedical Informatics, 2010
- Challenges in conducting clinical trials in children: approaches for improving performanceExpert Review of Clinical Pharmacology, 2009
- DrugBank: a knowledgebase for drugs, drug actions and drug targetsNucleic Acids Research, 2007
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- ThalidomideThe Lancet, 2004
- SildenafilDrugs, 1999